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Two human neuroblastoma cell lines, LAN-5 and GI-CA-N, have been analyzed for their capability to adhere to different extracellular matrix 
(ECM) components. The GI-CA-N cells adhered to all the tested substrates: laminin (LN), type I and type IV collagen (Co11 I, Co11 IV), vitronectin 
(VN), and fibronectin (FN). Conversely LAN-5 cells weakly attached to FN and VN, whilst adhesion on LN and Co11 I and IV was strong and 
induced a rapid elongation of cell processes. By means of RT-PCR and immunoprecipitation we showed that the integrin pattern of these two lines 
was different and could explain their diversity in adhesion capability. Both cell lines express a large amount of the j?, integrin subunit, associated 
with different a chains, probably responsible for their adhesion to some ECM proteins. After treatment of LAN-5 cells with biological differentiating 
agents, such as y-interferon, alone or in combination with tumour necrosis factor-a (TNF-a), or retinoic acid, the levels of a&I], o&, and a& 
mtegrin expression were enhanced, while the amount of &, remained constant. In contrast, treatment of LAN-5 cells with TNF-a, that did not 
induce any maturation, or starvation in 2% foetal calf serum, that inhibited cell proliferation without affecting neural differentiation, did not induce 
any change in the integrin assessment. Messenger-RNAs for the two as isoforms, A and B, were present in both cell lines. However, in LAN-5 
cells, the protein product was neither detectable nor inducible by differentiation. Our results confirm the specific modulation of the a#, integrin 
expression in human neuronal development, and show, for the first time, the involvement of azjI, and as/?, heterodimers in this maturational 
process. 
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1. INTRODUCTION 
Integrins are a complex family of heterodimeric mem- 
brane glycoproteins that mediate cell-to-cell and cell-to- 
extracellular matrix (ECM) interactions [l-3]. They 
play critical roles during development and cell differen- 
tiation [4] and are involved in tumorigenic processes 
such as invasion and metastasis [4,5]. In the nervous 
system integrins are the major class of adhesion recep- 
tors and mediate the differentiating effects of ECM 
components on neural cells during development [6]. 
Among the ECM proteins, laminin (LN) has an impor- 
tant role in promoting neurite outgrowth and extension 
in several nerve cell types [6,7]. Neural cells recognize 
LN through integrin receptors [8]. The q/3, and a& 
laminin receptors have been identified in cultures of 
neuronal cells showing support neurite extension [9,10]. 
Moreover, cl& expression is up-regulated in neuroblas- 
toma cells (NB) induced to differentiate by retinoic acid 
(RA) [ll]. The a& integrin has been demonstrated to 
bind LN in the retina and to be involved in the early 
development of the optic fiber [12]. The differential ex- 
pression of the A and B isoforms of the cc, subunit was 
shown to be related to various stages of maturation in 
mouse ES cells [13] suggesting a relationship with cell 
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differentiation processes. Among the integrins, ~1, is an- 
other subunit whose expression can be modulated by 
cytokines and differentiating factors in various cell 
types [14,15], being probably involved in cell differen- 
tiation. 
NB cells are a useful model system to study neuronal 
differentiation [161. These cells can be induced to differ- 
entiate to a neuronal morphology upon treatments with 
y-interferon (y-IFN) [17], RA [18], and combination of 
y-IFN and tumour necrosis factor-a (TNF-a) [193. In 
this paper we analyzed the adhesion properties, integrin 
expression, and morphological changes due to ECM- 
integrin interactions in the neuronal model. Moreover, 
the involvement of specific integrins in neuroblast dif- 
ferentiation has been investigated. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Human recombinant I-IFN and human recombinant TNF-a were 
generous gifts of Genentech Inc. (South San Francisco, CA, USA); 
they were stored in aliquots (30,000 III/PI) at -80°C. RA (Sigma, St. 
Louis, MO, USA) was prepared at 10m3 M in DMSO every week and 
kept at -20°C. All the other reagents of biochemistry and molecular 
biology grade were obtained from Sigma. 
2.2. Cell cultures and treatments 
LAN-5 NB cell line was a gift of R. Seeger [20]. GI-CA-N cell line 
was established and characterized in our laboratory [21]. Cells were 
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maintained in the logarithmic phase of growth in 75 cm2 plastic culture 
flasks (Costar, Cambridge, MA, USA) in RPM1 1640 medium 
(Seromed, Biochrom K.G., Berlin, Germany), supplemented with so- 
dium penicillin G (50 Iv/ml), and streptomycin sulfate (50 @ml) 
(complete medium) containing 15% heat-inactivated foetal calf serum 
(FCS) (Seromed) at 37’C in a 5% COr/95% air-humidified incubator. 
Cells were split following treatment with 1 mM EDTA in Hank’s salt 
solution (Seromed), washed, counted, and re-plated in fresh complete 
medium. Cells were treated with 1,000 IU/ml I-IFN, or 200 IUlml 
TNF, or 10m6 M RA, or starved in 2% FCS-complete medium for 
different times, as previously reported [22,23]. 
2.3. Cell adhesion assay 
GI-CA-N and LAN-5 NB cells were harvested with ice-cold phos- 
phate-buffered saline (PBS) without Car’ and Mg2’ (Seromed), resus- 
pended in RPM1 1460 medium without FCS and seeded on 96-well 
plates (Costar), previously coated with different ECM substrates, re- 
spectively at a density of 1 x 10’ or 2.5 x IO5 cells/well. Adhesion 
assays were performed as previously described [13]. Briefly, wells were 
coated with LN, vitronectin (VN), fibronectin (FN), collagen type I 
(Co11 I) and type IV (Co11 IV) (10 pg/ml each, Sigma) or with 1% 
poly-n-lysine (Polyscience Inc., Warrington, PA, USA) in PBS. Coat- 
ing was performed overnight at 4”C, then the plates were washed twice 
with PBS and incubated for 1 h at room temperature with 0.1% BSA 
in PBS. After two additional washes of the wells with PBS, cells were 
plated and incubated for 1 h at 37°C. Unattached cells were washed 
out with PBS and adherent cells were fixed for 5 min with 3% formal- 
dehyde, 2% sucrose in PBS, stained with 0.5% Cresyl violet in 20% 
methanol for 15 min, and washed with water. After solubilization with 
0.1 M citric acid in 50% ethanol (pH 4.2) A, was measured by a 
microplate reader (Metertech, Model zP60). The percentage of cells 
attached to ECM-coated cells was calculated as described by Hall et 
al. [24]. 
2.4. RNA extraction and reverse transcriptase-polymerase chain reac- 
tion (RT-PCR) 
Total RNA was extracted from NB cells using the guanidine-iso- 
thiocanate and phenol/chloroform method [25]. Briefly, the guanidine 
suspension containing the cell lysate was phenol/chloroform extracted 
and the aqueous phase precipitated with absolute ethanol at -20°C. 
The pellet was then washed twice with 70% ethanol, dried and resus- 
pended in sterile water. Onepg of RNA was utilized for each RT-PCR 
amplification using a thermal cycler (Perkin Elmer Corporation, Nor- 
walk, CT, USA) as previously described [26]. The specific primers for 
a,, a2, a,, a,, a,, a6, K, B , ,& /Jr B,,and /$, were synthesized with an 
Applied BioSystem Oligonucleotide Syntesizer 391 following the 
standard procedures, on the base of the integrins cDNA published 
sequences. The samples were analyzed on 2% agarose gel electropho- 
resis containing 0.1 &ml ethidium bromide. 
2.5. Cell surface iodination and immunoprecipitation 
Cells were grown up to five days in the presence or absence of the 
various differentiation-inducing agents, and then harvested with 
0.04% EDTA. After 3 washes with PBS, cells were resuspended inPBS 
at a density of about 5 x lO’/ml and radioiodinated with 2 mCi/ml of 
Na’251 (sp. act. 100 mCi/ml; ICN, Costamesa, CA, USA) for 10 min 
at room temperature using 300 pg/ml of lactoperoxidase (Sigma) and 
0.003% Hz02. After labeling, the cells were lysed with 0.5% Triton 
X-100, 1 mM MgCl,, 1 mM CaCl,, 4 mM PMSF, 2 &ml Pepstatin, 
2 &ml Leupeptin (Boehringer Mannheim Corporation, Indianapolis, 
IN. USA), 2 &ml Aprotinin (Sigma) in T&-buffered saline for 60 
min on ice. The lysates were clarified adding 1110 of volume of Pan- 
sorbin (Calbiochem, San Diego, CA, USA) and centrifuged at 40,000 
rpm for 60 min at 4°C. The supematants were then utilized for the 
immunoprecipitation experiments. 
The following antibodies were kindly provided by the listed investi- 
gators: rabbit polyclonal antisera/$ cyt [ll], a2 cyt, aj cyt, a, cyt [27], 
G. Tarone, University of Turin, Italy; rabbit polyclonal antisera anti- 
a,-A, anti-a,-B [28], anti-/I4 6944, anti&, V Quaranta, Scripps Clinic, 
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La Jolla, CA, USA; mouse monoclonal antibody anti-a, LM142 [29], 
D. Cheresh, Scripps Clinic. The other antibodies were purchased as 
listed: rabbit polyclonal antibody anti-a, (Chemicon Temecula, CA, 
USA), mouse monoclonal antibody anti-a, (Calbiochem), mouse 
monoclonal antibody ant@ Y2/51 (Dakopatts A/S, Glostrup, Den- 
mark). 
Antibodies were adsorbed onto protein G-agarose (Pierce, Rock- 
ford, IL, USA) by incubation for 1 h at 4’C with rotation in 10 mM 
Tris-HCl, pH 8.5, 150 mM NaCl, 0.5% Tween 20, 0.1% Renex, 0.01% 
ovalbumin, 2.5 mM NaN, (PORT). These immunoabsorbents were 
incubated overnight at 4’C with aliquots of radioiodinated cell lysates 
diluted in PORT, washed several times and eluted by boiling m 
Laemmli sample buffer [30]. Samples were analyzed by SDS-PAGE 
on 7.5% polyacrylamide g ls, followed by autoradiography on Hyper- 
film MP (Amersham Buckinghamshire, UK). 
3. RESULTS AND DISCUSSION 
3.1. Adhesion properties of neuroblastoma cells 
Cell adhesion assays using GI-CA-N and LAN-5 NB 
cell lines showed different capabilities of these cells to 
attach to ECM components. GI-CA-N cells were capa- 
ble of attaching in the absence of FCS to all the tested 
substrates (LN, Co11 I, Co11 IV, VN, and FN) (Fig. 1). 
LAN-5 cells attached well to Co11 I, Co11 IV, and LN, 
whilst they weakly adhere to VN and FN (Fig. 1). These 
differences in adhesion capabilities could be related to 
different adhesion receptor patterns in the two NB cell 
lines which may correspond to different stages of neural 
crest-derived cell maturation [20,21]. When plated on 
purified ECM components these NB cells assumed dif- 
ferent morphologies, spreading on the coated plastic 
surface and elongating neurites (Fig. 2). In both cell 
lines the effects of LN, Co11 I and Co11 IV on neurite 
outgrowth was evident, confirming previous results in 
pheocromocytoma [31,32] and after NB models [l 11. 
3.2. Integrin patterns of LAN-5 and GI-CA-N cells 
Integrin expression of both NB cell lines was ana- 
lyzed at the mRNA level by means of RT-PCR amplifi- 
FN Cdl I 
Fig. 1. Adhesion properties of GI-CA-N and LAN-5 NB cells on 
different ECM proteins. The data are expressed as percentage of the 
O.D. obtained by cells attached to poly-o-lysine and are representative 
of a typical experiment of three, each done in duplicate. 
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Fig. 2. Morphologies of GI-CA-N (A-F) and LAN-5 (G-L) NB cells 
on different ECM proteins after 3 h of adhesion in the presence of 
RPM1 1640 without FCS. A,G = poly-o-lysine; B,H = Co11 IV; 
C,I = Co11 I; D,L = LN; E = VN; F = FN. 
cation of total RNA using subunit-specific synthetic 
oligonucleotides, and at the protein level by im- 
munoprecipitation of surface radioiodinated cell ly- 
sates, using specific anti-integrin antibodies (Table I). 
As expected from the adhesion results, the integrin pat- 
tern of the two lines was different. Both expressed j?, at 
high levels, but it associated with different a chains in 
GI-CA-N and LAN-5 cells. In particular, the absence 
of a, and a, subunits in LAN-5 cells could explain the 
weaker adhesion to FN, compared to GI-CA-N cells 
(Fig. l), which express these integrin subunits (Table I). 
For the a6 subunit we performed PCR amplifications 
using primers designed on the sequence codifying for 
the cytoplasmic portion of this molecule, which presents 
two different isoforms: a,A and a,B [27]. In LAN-5 cells 
the a,B, described in mouse embryonic stem cells as the 
typical form of immature stages [13], was prevailing. 
This could reflect the low stage of maturation of LAN-5 
eels according to the NB cell classification by Ciccarone 
et al. [33]. Moreover, the adhesion of GI-CA-N and 
LAN-5 cells to LN seems to be mediated by different 
receptors, since the a& LN receptor was highly ex- 
pressed in GI-CA-N and not expressed in LAN-5 cells 
which might adhere to LN through a& a& or a& 
(Table I). The last three molecules could be responsible 
also for LAN-5 adhesion to Co11 I and Co11 IV. How- 
ever, the presence in this cell line of mRNAs codifying 
for the a,+, a6 and /I4 subunits, in the absence of the 
corresponding protein products (Table I), suggests the 
existence of post-transcriptional regulation mechanisms 
for the expression of such integrin subunits. 
3.3. Involvement of integrin expression in LAN-5 cells 
differentiation 
To elucidate the possible implication of these inte- 
grins during neuronal maturation we analyzed the 
changes in their expression after differentiation of 
LAN-5 cells. We previously showed that y-IFN is able 
to inhibit proliferation and induce neural differentiation 
of NB cells [17] and its effect is enhanced by combina- 
tion treatment with TNF-a [19]. LAN-5 cells are highly 
responsive to these treatments and to the treatment with 
RA, acquiring a differentiated phenotype with in- 
creased expression of neurofilament and microtubule 
associated proteins, and showing biochemical markers 
of neural maturation [17-19,22,23]. We supposed that 
also the integrin pattern of LAN-5 cells could have been 
modified reflecting, or perhaps contributing to the 
changes in their phenotype and behavior. To test this 
Table I 
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+++= +++ +++ +++ 
+ + - 
+ + + + 
+ + + + 
+ - + + 
- - ++ + 
+ - +++ +++ 
+++ - + + 
++ + ++ ++ 
+ + + n.d. 
+ - - _ 
+ n.d. + n.d. 
- - - - 
‘data obtained by RT-PCR (n = 3). 
bdata obtained by immunoprecipitation (  = 3). 
’ - negative; f equivocally positive; + moderately positive; ++ posi- 
tive; +++ strongly positive; n.d. not done. 
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Fig. 3. Expression of /3,, a,, aa and B mRNAs during NB cell 
differentiation. The figure shows RT-PCR amplifications of mRNAs 
for the integrin subunits: (A) B,; (B) a,; (C) a, A and B isoforms; (D) 
for the G3PDH ‘housekeeping’ gene. Total RNAs from untreated 
LAN-5 cells (lanes 1, 14) or treated with y-IFN (1,000 IU/ml) (lanes 
2-S), with RA ( 10m6 M) (lanes 6-9), and with y-IFN + TNF-a (1,000 
W/ml, 200 III/ml, respectively) (lanes l&13), were extracted after 1 
(lanes 2, 6, lo), 3 (lanes 3, 7, ll), 5 (lanes 4, 8, 12) and 7 days (lanes 
5,9, 13) of treatments and utilized for the RT-PCR experiments. The 
molecular size standards on the left are the 123 kb DNA ladder (panel 
A, B, and C) and the 4x174 RF DNA-Hue111 digest (panel D). 
hypothesis, LAN-5 cells were treated with I/-IFN, y- 
IFN + TNF-a, or RA, and total RNA was extracted at 
different time intervals and utilized for RT-PCR exper- 
iments. Oligonucleotide primers specific for /3r, 01,, and 
as chains have been used and the results are shown in 
Fig. 3. Although the alternative expression of the two 
a6 isoforms seems to be related to the differentiation 










stage of the cell, the a,B being the typical form of imma- 
ture stages in the mouse embryonic stem cells [ 131. we 
did not observe any shift between the two isoforms in 
all treated samples (Fig. 3C). In some experiments, a 
non-consistent enhancement of both isoforms was 
noted. No significant changes in mRNA expression 
were seen forpr and a, subunits (Fig. 3A and B, respec- 
tively), although their expression has been shown to be 
regulated by various cytokines in different cell models 
[ 11,13-l 51. The pattern of expression of the correspond- 
ing protein products after 5 days of treatment was then 
analyzed by immunoprecipitation of lysates from 
treated or untreated, surface radioiodinated, LAN-5 
cells (Fig. 4). A significant enhancement of the a#, 
heterodimer was seen in LAN-5 cells treated with RA, 
)I-IFN and, even stronger, with the combination of y- 
IFN and TNF-a (Fig. 4A,B, lanes 5. 2, and 3, respec- 
tively). y-IFN itself, or together with TNF-a enhanced 
the expression also of the integrins a& and a$,, which 
were not induced by RA treatment (Fig. 4C,D, lanes 2, 
3, and 5). No integrin enhancement was visible when 
LAN-5 were treated with TNF-a alone (Fig. 4, lanes 5), 
which has no differentiating effect by itself on these cells 
[19,23]. Moreover, in cells in which the proliferation 
rate was arrested by starvation with 2% FCS-containing 
medium without affecting cell maturation [23], the 
amounts of such integrins (Fig. 4, lanes 6) were compa- 
rable to those seen in the untreated cells (lanes 1). These 
data support the relationship of the modulation of these 
integrins with LAN-5 neural differentiation independ- 
ently from the proliferative stop itself. On the other 
hand, the levels of cl, and j& were the same in treated 
or untreated cells (Fig. 4E,F), suggesting that these sub- 
units are probably not involved in neural differentia- 
tion. The anti-p4 6944 antibody did not precipitate any 
protein in untreated or treated LAN-5 cells (Fig. 4H), 








Fig. 4. Integrins expression in neuroblast differentiation induced by J-IFN, y-IFN + TNF-a, and RA. The figure shows immunoprecipitations 
of surface radioiodinated cell lysates of LAN-5 cells: untreated (lanes 1) or treated for 5 days with J-IFN (lanes 2), y-IFN + TNF-a (lanes 3), TNF-a 
(lanes 4), RA (lanes 5). at the concentration listed in the legend of Fig. 3, or starved with 2% FCS (lanes 6). In lower right panel a positive control 
for anti-a, and anti-B, antibodies is shown, obtained by immunoprecipitation of an A431 cell lysate. Molecular mass markers are in kilodaltons. 
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showing that the y-IFN or RA-induced differentiation 
did not activate the transduction of the p4 mRNA pres- 
ent in these cells. Also the anti-ahA antibody (Fig. 4G) 
and the anti-a,B antibody (data not shown) did not 
react with any protein in the treated or untreated LAN- 
5 cells in spite of the presence of as encoding mRNA. 
The last finding is supported by the immunoprecipita- 
tion of p4 and a6 subunits in A43 1 cells used as a positive 
control (Fig. 4). In conclusion, the up-modulation of the 
a,/$ integrin observed during the course of neuronal 
differentiation of LAN-5 cells induced by all the pro- 
moting agents, confirms previously reported data using 
RA on NB cells [l l] and NGF on PC-12 cells [30] and 
points to a possible generic role for this heterodimer in 
neurite outgrowth [30]. In contrast, the dramatic up- 
regulation of the aJ?i and a$1 heterodimers by y-IFN 
and y-IFN + TNF treatments, more potent ditferentiation- 
inducing protocols [19,22,23], suggests different path- 
ways of activation for the three integrins and different 
functional roles in neuronal cell maturation. Although 
preliminary results seem to indicate that treatment of 
NB cells with these differentiating agents induces en- 
hanced adhesion and neurite extension on LN, Co11 I, 
and Co11 IV (C. ROZZO, unpublished results), the ques- 
tion of whether the induced expression of these matrix 
receptors is an essential aspect of the regulation of 
neurite extension in NB cells is still under investigation. 
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